Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its antineoplastic activity

Phytotherapy Research

Volumn 19, Issue 9, 2005, Pages 772-778

  Jagetia, Ganesh Chandra ^a   Reddy, Tiyyagura Koti ^a   Malagi, Krishna Jayacharya ^a   Nayak, Bijoor Shivananda ^a   Naidu, Menda Balachandra Rao ^a   Ravikiran, Penumurthy Balaji ^a   Kamath, Shobha Ullas ^a   Shetty, Prukash Chandra ^a   Reddy, Dondapati Subba ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Antarth; Antioxidants and lipid peroxidation; Cardiotoxicity; Doxorubicin; Ehrlich ascites carcinoma

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPINIA GALANGA EXTRACT; ANTARTH; ASPARTATE AMINOTRANSFERASE; BLACK PEPPER EXTRACT; BOERHAAVIA DIFFUSA EXTRACT; BOSWELLIA SERRATA EXTRACT; COMMIPHORA MUKUL EXTRACT; CREATINE KINASE MB; DOXORUBICIN; EMBLICA OFFICINALIS EXTRACT; GINGER EXTRACT; HERBACEOUS AGENT; LACTATE DEHYDROGENASE; PIPER LONGUM EXTRACT; PLANT EXTRACT; SHUDDHA SHILAJIT; SMILAX CHINA EXTRACT; TERMINALIA BELRICA EXTRACT; TERMINALIA CHEBULA EXTRACT; TINOSPORA CORDIFOLIA EXTRACT; TRIBULUS TERRESTRIS EXTRACT; TRIGONELLA FOENUM GRAECUM EXTRACT; UNCLASSIFIED DRUG; VITEX NEGUNDO EXTRACT; WITHANIA SOMNIFERA EXTRACT;

ALPINIA; ALPINIA GALANGAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLACK PEPPER; BOERHAAVIA DIFFUSA; BOSWELLIA; BOSWELLIA SERRATA; CANCER SURVIVAL; CARDIOTOXICITY; COMMIPHORA; CONTROLLED STUDY; CURCUMA LONGA; DISEASE MARKER; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EHRLICH ASCITES TUMOR; EMBLICA OFFICINALIS; ENZYME BLOOD LEVEL; FENUGREEK; GINGER; HEART PROTECTION; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PIPER LONGUM; PIPERACEAE; SARSAPARILLA; SMILAX CHINA; SURVIVAL TIME; TERMINALIA; TERMINALIA BELERICA; TERMINALIA CHEBULA; TINOSPORA; TINOSPORA CORDIFOLIA; TRIBULUS TERRESTRIS; VITEX; VITEX NEGUNDO; WITHANIA SOMNIFERA;

ADMINISTRATION, ORAL; ALANINE TRANSAMINASE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; CREATINE KINASE; DOXORUBICIN; DRUG THERAPY, COMBINATION; HEART DISEASES; INJECTIONS, INTRAPERITONEAL; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; MICE; MYOCARDIUM; PHYTOTHERAPY; PLANT PREPARATIONS; PROTECTIVE AGENTS;

ALPINIA; ALPINIA GALANGA; ANIMALIA; BOERHAAVIA DIFFUSA; BOSWELLIA; BOSWELLIA SERRATA; COMMIPHORA; COMMIPHORA MUKUL; CURCUMA LONGA; KAEMPFERIA GALANGA; PHYLLANTHUS EMBLICA; PIPER LONGUM; PIPER NIGRUM; PIPERACEAE; SMILAX ARISTOLOCHIIFOLIA; SMILAX CHINA; TERMINALIA; TERMINALIA CHEBULA; TINOSPORA; TINOSPORA CORDIFOLIA; TRIBULUS TERRESTRIS; TRIGONELLA FOENUM GRAECUM; VITEX; VITEX NEGUNDO; WITHANIA SOMNIFERA; ZINGIBER OFFICINALE;

EID: 27644537614     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1713     Document Type: Article

References (35)

1. Abei H. 1984. Catalase in vitro. Methods Enzymol 105: 121-126.
2. Bachur NR, Gordon SL, Gee MW. 1978. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res 38: 1745-1750.
3. Bergmeyer HU, Bernet E. 1974. Lactate dehydrogenase isoenzymes UV assay after separation on DEAE sephadex. In Methods of Enzymatic Analysis, Bermeyer HU (ed.). Verlag Chemie: Weinheim.
4. Bhattacharya A, Ghosal S, Bhattacharya SK. 2001. Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. J Ethnopharmacol 74: 1-6.
5. Fahey JW, Stephenson KK. 2002. Pinostrobin from honey and Thai ginger (Boesenbergia pandurata): a potent flavonoid inducer of mammalian phase 2 chemoprotective and antioxidant enzymes. J Agric Food Chem 50: 7472-7476.
6. Gelvan, Saltman P. 1990. Different cellular targets of Cu- and Fe-catalyzed oxidation observed using a Cu-compatible thiobarbiturate acid assay. Biochim Biophys Acta 1035: 353-360.
7. Genet S, Kale RK, Baquer NZ. 2002. Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: effect of vanadate and fenugreek (Trigonellafoenum graecum). Mol Cell Biochem 236: 7-12.
8. Green MD, Alderton P, Gross J, Muggia FM, Speyer JL. 1990. Evidence of the selective alteration of anthracycline activity due to modulation by ICRF-187 (ADR-529). Pharmacol Ther 48: 61-69.
9. Wu HY, Kang J. 1998. Inhibition of buthionine sulfoximine - enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart. J Pharmacol Exp Ther 287: 515-520.
10. Kachmar JF, Moss DW. 1982. Enzymes. In Fundamentals of Clinical Chemistry, Tietz W (ed.). W. B. Saunders: Philadelphia; 565-595.
11. Kalyanaraman B, Sealy RC, Sinha BK. 1984. An electron spin resonance study of the reduction of peroxides by anthracycline semiquinones. Biochim Biophys Acta 779: 270-275.
12. Keizer HG, Pinedo HM, Schuurhuis GJ, Joenje H. 1990. Doxorubicin (Adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol Ther 47: 219-231.
13. Kulkarni RD. 1997. Principles of Pharmacology in Ayuerveda. Ram Sangam Graphics: Mumbai, India.
14. Marklund S, Marklund G. 1974. Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47: 469-474.
15. Messinger Y, Uckun FM. 1999. A critical risk-benefit assessment argues against the use of anthracyclines in induction regimens for newly diagnosed childhood acute lymphoblastic leukemia. Leuk Lymphoma 34: 415-432.
16. Moron MS, Depierre JW, Mannervik B. 1979. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582: 67-78.
17. Munasinghe J, Seneviratne CK, Thabrew MI, Abeysekera AM. 2001. Antiradical and antilipoperoxidative effects of some plant extracts used by Sri Lankan traditional medical practitioners for cardioprotection. Phytother Res 15: 519-523.
18. Myers CE, McGuire WP, Liss RH, Ifrim I, Grotzinger K, Young RC. 1977. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science 197: 165-167.
19. Quiles JL, Aguilera C, Mesa MD, Ramirez-Tortosa MC, Baro L, Gil A. 1998. An ethanolic-aqueous extract of Curcuma longa decreases the susceptibility of liver microsomes and mitochondria to lipid peroxidation in atherosclerotic rabbits. Biofactors 8: 51-57.
20. Hrdina R, Geršl V, Klimtová I, Šimùnek T, Macháèková J, Adamcová M. 2000. Anthracycline- induced cardiotoxicity. Acta Med 43: 75-82.
21. Reitman S, Frankel SA. 1957. Colorimetric method for determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase. Am J Clin Pathol 28: 56-60.
22. Sabu MC, Kuttan R. 2002. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. Ethnopharmacology 81: 155-160.
23. Sandermann H, Stromiger J. 1972. Purification and properties of C55-isoprenoid alcohol phosphokinase from Staphylococcus aureus. J Biol Chem 247: 5123-5130.
24. Sato M, Bremner I. 1993. Oxygen free radicals and metallothionein. Free Radic Biol Med 14: 325-337.
25. Satoh M, Naganuma A, Imura IM. 1998. Involvement of cardiac metallothionein in prevention of adriamycin induced lipid peroxidation in the heart. Toxicology 53: 231-237.
26. Shan K, Lincoff AM, Young JB. 1996. Anthracycline-induced cardiotoxicity. Ann Intern Med 125: 47-58.
27. Singal PK, Iliskovic N. 1998. Doxorubicin-induced cardiomyopathy. N Engl J Med 339: 990-905.
28. Sparano JA. 1998. Use of dexrazoxane and other strategies to prevent cardiomyopathy associated with doxorubicin-taxane combinations. Semin Oncol 25: 66-71.
29. Speyer JL, Green MD, Zeleniuch-Jacquotte A et al. 1992. MICRF-187 permits longer treatment with doxorubicin in women with breast cancer. J Clin Oncol 10: 117-127.
30. Subramanian M, Chintalwar GJ, Chattopadhyay S. 2002. Antioxidant properties of a Tinospora cordifolia polysaccharide against iron-mediated lipid damage and gamma-ray induced protein damage. Redox Rep 7: 137-143.
31. Takács IE, Matkovics B, Varga SI, Homolay P, Feh́r G, Seres T. 1992. Study of the myocardial antioxidant defense in various species. Pharmacol Res 25: 177-178.
32. Van Acker FA, Boven E, Kramer K, Haenen GR, Bast AR, Vander Vijgh WJ. 2001. Frederine, a new and promising protector against doxorubicin-induced cardiotoxicity. Clin Cancer Res 7: 1378-1384.
33. Venkatesan N. 1998. Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br J Pharmacol 124: 425-427.
34. Weiss RB. 1992. The anthracyclines: Will we ever find a better doxorubicin. Semin Oncol 19: 670-686.
35. Zhou S, Starkov A, Froberg MK, Leino L, Wallace KB. 2001. Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin. Cancer Res 15: 771-777.